Alexa A. Pragman

2.1k total citations
29 papers, 1.4k citations indexed

About

Alexa A. Pragman is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Emergency Medical Services. According to data from OpenAlex, Alexa A. Pragman has authored 29 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 12 papers in Emergency Medical Services. Recurrent topics in Alexa A. Pragman's work include Pediatric health and respiratory diseases (12 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers) and Gut microbiota and health (10 papers). Alexa A. Pragman is often cited by papers focused on Pediatric health and respiratory diseases (12 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers) and Gut microbiota and health (10 papers). Alexa A. Pragman collaborates with scholars based in United States, United Kingdom and Netherlands. Alexa A. Pragman's co-authors include Richard E. Isaacson, Patrick M. Schlievert, Cavan Reilly, Christine Wendt, Hyeun Bum Kim, Jeremy M. Yarwood, Timothy J. Tripp, Chris H. Wendt, Trevor J. Gould and Ken M. Kunisaki and has published in prestigious journals such as PLoS ONE, Biochemistry and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Alexa A. Pragman

28 papers receiving 1.4k citations

Peers

Alexa A. Pragman

PRM

EMS

EPIDE

Lisa McCloskey United States

Marian García-Núñez Spain

David J. Serisier Australia

Eric Bernasconi Switzerland

J. Foweraker United Kingdom

Luís Máiz Spain

Grégoire Wieërs Belgium

Danielle Ahn United States

Nicolas Kalach France

Thomas J. Kirn United States

Lisa McCloskey United States

Alexa A. Pragman

992 ×1.5

879 ×1.5

PRM

211 ×0.5

520 ×2.1

EMS

374 ×1.7

EPIDE

Citations per year, relative to Alexa A. Pragman Alexa A. Pragman (= 1×) peers Lisa McCloskey

Countries citing papers authored by Alexa A. Pragman

Since Specialization

Citations

This map shows the geographic impact of Alexa A. Pragman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexa A. Pragman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexa A. Pragman more than expected).

Fields of papers citing papers by Alexa A. Pragman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexa A. Pragman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexa A. Pragman. The network helps show where Alexa A. Pragman may publish in the future.

Co-authorship network of co-authors of Alexa A. Pragman

This figure shows the co-authorship network connecting the top 25 collaborators of Alexa A. Pragman. A scholar is included among the top collaborators of Alexa A. Pragman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexa A. Pragman. Alexa A. Pragman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nelson, Ryan, et al.. (2024). Evaluation of Inborn Errors of Immunity Among Patients with Opportunistic Pulmonary Infection. Clinics in Chest Medicine. 46(1). 61–75.

Pragman, Alexa A., et al.. (2023). Sputum microbiome α-diversity is a key feature of the COPD frequent exacerbator phenotype. ERJ Open Research. 10(1). 595–2023. 4 indexed citations

Chotirmall, Sanjay H., Debby Bogaert, James D. Chalmers, et al.. (2022). Therapeutic Targeting of the Respiratory Microbiome. American Journal of Respiratory and Critical Care Medicine. 206(5). 535–544. 41 indexed citations

Klein, Mark, Alexa A. Pragman, & Christine Wendt. (2022). Biomarkers and the microbiome in the detection and treatment of early-stage non-small cell lung cancer. Seminars in Oncology. 49(3-4). 285–297. 3 indexed citations

Pragman, Alexa A., et al.. (2021). Chlorhexidine oral rinses for symptomatic COPD: a randomised, blind, placebo-controlled preliminary study. BMJ Open. 11(12). e050271–e050271. 7 indexed citations

Pragman, Alexa A., et al.. (2020). The Oral-Lung Axis: The Impact of Oral Health on Lung Health. Respiratory Care. 65(8). 1211–1220. 53 indexed citations

Pragman, Alexa A., et al.. (2020). Modeling the Lung Microbiota: The Neutral Theory of Community Ecology. A5411–A5411. 1 indexed citations

Pragman, Alexa A., et al.. (2020). 634. Chlorhexidine Oral Rinses to Alter the Oral and Sputum Microbiota in COPD (CLIMB): a Randomized, Double-blinded, Placebo-controlled, Parallel-group Pilot Study. Open Forum Infectious Diseases. 7(Supplement_1). S377–S377. 1 indexed citations

Baldomero, Arianne K., Mariam Siddiqui, Ashley Petersen, et al.. (2019). <p>The relationship between oral health and COPD exacerbations</p>. International Journal of COPD. Volume 14. 881–892. 29 indexed citations

10.

Pragman, Alexa A., et al.. (2019). Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics. PLoS ONE. 14(7). e0219962–e0219962. 14 indexed citations

11.

Pragman, Alexa A., et al.. (2019). Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study. Respiratory Research. 20(1). 114–114. 31 indexed citations

12.

Pragman, Alexa A., Tianmeng Lyu, Joshua A. Baller, et al.. (2018). The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease. Microbiome. 6(1). 7–7. 101 indexed citations

13.

Kunisaki, Ken M., Mark T. Dransfield, Julie A. Anderson, et al.. (2018). Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 198(1). 51–57. 220 indexed citations

14.

Pragman, Alexa A., et al.. (2018). The Chronic Obstructive Pulmonary Disease Frequent Exacerbator Phenotype Is Associated with Decreased Upper Airway Microbiota α Diversity. Annals of the American Thoracic Society. 15(Supplement_4). S286–S286. 2 indexed citations

15.

Pragman, Alexa A., et al.. (2016). Understanding Persistent Bacterial Lung Infections. Clinical Pulmonary Medicine. 23(2). 57–66. 46 indexed citations

16.

Pragman, Alexa A., et al.. (2015). A Method for Determining Taxonomical Contributions to Group Differences in Microbiomic Investigations. Journal of Computational Biology. 22(10). 930–939. 1 indexed citations

17.

Pragman, Alexa A., et al.. (2014). The Lung Microbiome in Moderate and Severe Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society. 11(Supplement 1). S77–S78. 23 indexed citations

18.

Pragman, Alexa A., Michael A. Kuskowski, James Abraham, & Gregory Filice. (2012). Infectious Disease Consultation for Staphylococcus aureus Bacteremia Improves Patient Management and Outcomes. Infectious Diseases in Clinical Practice. 20(4). 261–267. 41 indexed citations

19.

Pragman, Alexa A., Hyeun Bum Kim, Cavan Reilly, Christine Wendt, & Richard E. Isaacson. (2012). The Lung Microbiome in Moderate and Severe Chronic Obstructive Pulmonary Disease. PLoS ONE. 7(10). e47305–e47305. 315 indexed citations

20.

McCormick, John K., et al.. (2001). Functional Characterization of Streptococcal Pyrogenic Exotoxin J, a Novel Superantigen. Infection and Immunity. 69(3). 1381–1388. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact